Among the most disputable prostate cancer drugs in the United States, enzalutamide under the trademark Xtandi is highly priced, having a high disparity from its price in other countries. https://www.whizolosophy.com/category/overall-health/article-column/costs-of-enzalutamide-in-the-us-price-and-savings-overview